
Jeffrey E. Russel
Examiner (ID: 13185, Phone: (571)272-0969 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1815, 1103, 1621, 1811, 1653, 1675, 2899, 1654, 1809 |
| Total Applications | 3437 |
| Issued Applications | 2371 |
| Pending Applications | 237 |
| Abandoned Applications | 837 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4824780
[patent_doc_number] => 20080124274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Compositions and methods for detecting and treating tumors containing acidic areas'
[patent_app_type] => utility
[patent_app_number] => 11/449508
[patent_app_country] => US
[patent_app_date] => 2006-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 26196
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20080124274.pdf
[firstpage_image] =>[orig_patent_app_number] => 11449508
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/449508 | Compositions and methods for detecting and treating tumors containing acidic areas | Jun 6, 2006 | Abandoned |
Array
(
[id] => 4432761
[patent_doc_number] => 07897561
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-01
[patent_title] => 'Methods for treatment or prophylaxis of atherosclerosis and reperfusion injury'
[patent_app_type] => utility
[patent_app_number] => 11/916760
[patent_app_country] => US
[patent_app_date] => 2006-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 9306
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/897/07897561.pdf
[firstpage_image] =>[orig_patent_app_number] => 11916760
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/916760 | Methods for treatment or prophylaxis of atherosclerosis and reperfusion injury | Jun 4, 2006 | Issued |
Array
(
[id] => 4477356
[patent_doc_number] => 07906485
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-15
[patent_title] => 'Erythropoietin receptor peptide formulations and uses'
[patent_app_type] => utility
[patent_app_number] => 11/916416
[patent_app_country] => US
[patent_app_date] => 2006-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36241
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/906/07906485.pdf
[firstpage_image] =>[orig_patent_app_number] => 11916416
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/916416 | Erythropoietin receptor peptide formulations and uses | Jun 4, 2006 | Issued |
Array
(
[id] => 5850556
[patent_doc_number] => 20060233747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Polymer-modified synthetic proteins'
[patent_app_type] => utility
[patent_app_number] => 11/446419
[patent_app_country] => US
[patent_app_date] => 2006-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 58609
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20060233747.pdf
[firstpage_image] =>[orig_patent_app_number] => 11446419
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/446419 | Polymer-modified synthetic proteins | Jun 4, 2006 | Abandoned |
Array
(
[id] => 285506
[patent_doc_number] => 07550433
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-23
[patent_title] => 'Erythropoietin receptor peptide formulations and uses'
[patent_app_type] => utility
[patent_app_number] => 11/446593
[patent_app_country] => US
[patent_app_date] => 2006-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36358
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/550/07550433.pdf
[firstpage_image] =>[orig_patent_app_number] => 11446593
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/446593 | Erythropoietin receptor peptide formulations and uses | Jun 1, 2006 | Issued |
Array
(
[id] => 5027917
[patent_doc_number] => 20070269364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Diameter-selective reversible closable peptides'
[patent_app_type] => utility
[patent_app_number] => 11/441480
[patent_app_country] => US
[patent_app_date] => 2006-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6388
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269364.pdf
[firstpage_image] =>[orig_patent_app_number] => 11441480
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/441480 | Diameter-selective reversible closable peptides | May 25, 2006 | Issued |
Array
(
[id] => 5465656
[patent_doc_number] => 20090325856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'Composition Designed For The Treatment Of Multiple Sclerosis'
[patent_app_type] => utility
[patent_app_number] => 11/915532
[patent_app_country] => US
[patent_app_date] => 2006-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6182
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325856.pdf
[firstpage_image] =>[orig_patent_app_number] => 11915532
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/915532 | Composition Designed For The Treatment Of Multiple Sclerosis | May 23, 2006 | Abandoned |
Array
(
[id] => 4733339
[patent_doc_number] => 20080050318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'Use of a combination of components with an inhibitory synergistic effect on calcium channels to prevent or treat wrinkles and fine lines'
[patent_app_type] => utility
[patent_app_number] => 11/434266
[patent_app_country] => US
[patent_app_date] => 2006-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6486
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20080050318.pdf
[firstpage_image] =>[orig_patent_app_number] => 11434266
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/434266 | Use of a combination of components with an inhibitory synergistic effect on calcium channels to prevent or treat wrinkles and fine lines | May 15, 2006 | Abandoned |
Array
(
[id] => 5080243
[patent_doc_number] => 20070123467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Amniotic-derived peptide and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/434525
[patent_app_country] => US
[patent_app_date] => 2006-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 24829
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20070123467.pdf
[firstpage_image] =>[orig_patent_app_number] => 11434525
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/434525 | Amniotic-derived peptide and uses thereof | May 14, 2006 | Abandoned |
Array
(
[id] => 307448
[patent_doc_number] => 07531514
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-12
[patent_title] => 'Orally administered peptides synergize statin activity'
[patent_app_type] => utility
[patent_app_number] => 11/431412
[patent_app_country] => US
[patent_app_date] => 2006-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 25306
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/531/07531514.pdf
[firstpage_image] =>[orig_patent_app_number] => 11431412
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/431412 | Orally administered peptides synergize statin activity | May 8, 2006 | Issued |
Array
(
[id] => 5040293
[patent_doc_number] => 20070092575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Compositions for administering RNAIII-inhibiting peptides'
[patent_app_type] => utility
[patent_app_number] => 11/430091
[patent_app_country] => US
[patent_app_date] => 2006-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9100
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20070092575.pdf
[firstpage_image] =>[orig_patent_app_number] => 11430091
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/430091 | Compositions for administering RNAIII-inhibiting peptides | May 8, 2006 | Abandoned |
Array
(
[id] => 4813848
[patent_doc_number] => 20080194479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Methods and Compositions to Treat Mucositis'
[patent_app_type] => utility
[patent_app_number] => 11/913928
[patent_app_country] => US
[patent_app_date] => 2006-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10024
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194479.pdf
[firstpage_image] =>[orig_patent_app_number] => 11913928
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/913928 | Methods and compositions to treat mucositis | May 8, 2006 | Issued |
Array
(
[id] => 5608086
[patent_doc_number] => 20060269602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Method of modifying the release profile of sustained release compositions'
[patent_app_type] => utility
[patent_app_number] => 11/429930
[patent_app_country] => US
[patent_app_date] => 2006-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9421
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20060269602.pdf
[firstpage_image] =>[orig_patent_app_number] => 11429930
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/429930 | Method of modifying the release profile of sustained release compositions | May 7, 2006 | Abandoned |
Array
(
[id] => 5705689
[patent_doc_number] => 20060194737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Hepta-, octa-and nonapeptides having antiangiogenic activity'
[patent_app_type] => utility
[patent_app_number] => 11/418667
[patent_app_country] => US
[patent_app_date] => 2006-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21356
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194737.pdf
[firstpage_image] =>[orig_patent_app_number] => 11418667
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/418667 | Hepta-, octa-and nonapeptides having antiangiogenic activity | May 4, 2006 | Abandoned |
Array
(
[id] => 558627
[patent_doc_number] => 07470663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-30
[patent_title] => 'Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same'
[patent_app_type] => utility
[patent_app_number] => 11/417586
[patent_app_country] => US
[patent_app_date] => 2006-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 36691
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/470/07470663.pdf
[firstpage_image] =>[orig_patent_app_number] => 11417586
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/417586 | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same | May 3, 2006 | Issued |
Array
(
[id] => 888162
[patent_doc_number] => 07348307
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-25
[patent_title] => 'Methionine aminopeptidase-2 inhibitors and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/416622
[patent_app_country] => US
[patent_app_date] => 2006-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 17753
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/348/07348307.pdf
[firstpage_image] =>[orig_patent_app_number] => 11416622
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/416622 | Methionine aminopeptidase-2 inhibitors and methods of use thereof | May 2, 2006 | Issued |
Array
(
[id] => 5297060
[patent_doc_number] => 20090011986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Thiosuccinic Acid Derivatives and the Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/914426
[patent_app_country] => US
[patent_app_date] => 2006-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7416
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0011/20090011986.pdf
[firstpage_image] =>[orig_patent_app_number] => 11914426
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/914426 | Thiosuccinic acid derivatives and the use thereof | May 2, 2006 | Issued |
Array
(
[id] => 6275264
[patent_doc_number] => 20100256063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'Method for Increasing Cardiac Mass and Performance'
[patent_app_type] => utility
[patent_app_number] => 11/913097
[patent_app_country] => US
[patent_app_date] => 2006-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7166
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256063.pdf
[firstpage_image] =>[orig_patent_app_number] => 11913097
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/913097 | Method for increasing cardiac mass and performance | May 1, 2006 | Issued |
Array
(
[id] => 53159
[patent_doc_number] => 07772179
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-10
[patent_title] => 'Photodynamic therapy using chemiluminescence and a ligand-photosensitiser conjugate'
[patent_app_type] => utility
[patent_app_number] => 11/918905
[patent_app_country] => US
[patent_app_date] => 2006-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 4904
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/772/07772179.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918905
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918905 | Photodynamic therapy using chemiluminescence and a ligand-photosensitiser conjugate | Apr 19, 2006 | Issued |
Array
(
[id] => 102639
[patent_doc_number] => 07723303
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response'
[patent_app_type] => utility
[patent_app_number] => 11/407390
[patent_app_country] => US
[patent_app_date] => 2006-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 49398
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723303.pdf
[firstpage_image] =>[orig_patent_app_number] => 11407390
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/407390 | Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response | Apr 17, 2006 | Issued |